跳至主要内容
临床试验/EUCTR2016-000789-53-AT
EUCTR2016-000789-53-AT进行中(未招募)1 期

A pilot trial to investigate the administration of von Willebrand factor concentrate (Willfact®, LFB France) in adult patients during extracorporeal membrane oxygenation - Willfact during ECMO

Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin0 个研究点开始时间: 2016年10月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients with the need of veno-arterial or veno-venous ECMO for a minimum of 48 hours
  • - Age = 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Patient with known thromboembolic event in the last 30 days
  • - Inevitable lethal course
  • - Severe Liver failure: Quick < 30 %
  • - Pregnancy
  • - Patient with known refusal of a participation in this clinical trial
  • - Active participation in another clinical trial
  • - Any condition, including the presence of laboratory abnormalities, which would place the subject at unacceptable risk if he/she were to participate in the study or confound the ability to interpret data from the study

研究者

发起方
Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin

相似试验

进行中(未招募)
不适用
A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autologous stem cell transplantation.Patients with - risk Non-Hodgkin's Lymphoma in complete or partial response who underwent autologous PBPC transplantation after high-dose chemiotherapy.MedDRA version: 6.1Level: HLTClassification code 10012819
EUCTR2005-004442-14-ITIVERSITA' DEGLI STUDI DI UDINE
已完成
不适用
A pilot clinical trial to evaluate the efficacy of acupuncture therapy and Needle-Embedding acupuncture therapy on Atopic DermatitisDiseases of the skin and subcutaneous tissue
KCT0003177DONGSHIN UNIVERSITY SUNCHEON ORIENTAL MEDICINE HOSPITYA14
尚未招募
2 期
Vel Tooth powder against dental biofilm and Gingival bleeding among Childre
CTRI/2023/09/058077ational Institute of Siddha
进行中(未招募)
1 期
Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19)COVID-19 infection is being spread around the world with more than 400.000 cases. The spred of the disease is being a world health problem.
EUCTR2020-001194-69-ESFélix Gutiérrez Rodero200
招募中
不适用
Pilot study to evaluate the efficacy and safety of MegaNuovo in Pressure sore patients : single center, comparative, investigator-initiated pilot studyDiseases of the skin and subcutaneous tissue
KCT0006745Yonsei University, Wonju Severance Christian Hospital30